1-20 of 67
Pier Paolo Piccaluga
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SOX11 in EBV-negative Burkitt lymphoma

Pier Paolo Piccaluga
Journal: Blood
Blood (2024) 144 (2): 128–129.
https://doi.org/10.1182/blood.2024024765
Published: 2024
Journal Articles

Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes with Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients with Chronic Lymphocytic Leukemia from Senegal

Abibatou Sall, MDPhD, Teresa Amato, MB, PhD, Alessandro Gozzetti, Awa Oumar Touré, MD PhD, Saliou Diop, MD MSc, Lorenzo Leoncini, Pier Paolo Piccaluga, MD PhD, Martine Raphaël, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-138827
Published: 2020
Journal Articles

Male-Biased Spliceosome Mutations in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Impair pDC Activation and Apoptosis

Katsuhiro Togami, MDPhD, Sun Sook Chung, PhD, Vikas Madan, PhD, Christopher M. Kenyon, BS, Lucia Cabal-Hierro, PhD, Justin Taylor, MD, Sunhee Kim, MD, Gabriel K Griffin, MD, Mahmoud Ghandi, Jia Li, PhD, Yvonne Y. Li, PhD, Fanny Angelot-Delletre, PhD, Sabeha Biichle, Michael Seiler, Silvia Buonamici, PhD, Scott B Lovitch, MDPhD, Abner Louissaint, Jr., MD PhD, Elizabeth A Morgan, MD, Fabrice Jardin, MD PhD, Pier Paolo Piccaluga, MD PhD, David M. Weinstock, MD, Peter S. Hammerman, MD PhD, Henry Yang, PhD, Marina Konopleva, MD PhD, Naveen Pemmaraju, MD, Francine Garnache-Ottou, PhD, Omar Abdel-Wahab, MD, H. Phillip Koeffler, MD, Andrew A Lane, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-137727
Published: 2020
Journal Articles

Tosedostat Plus Low Dose Cytarabine Induces a High Rate of Responses That Can be Predicted By Genetic Profiling in Elderly AML

Giuseppe Visani, MD, Federica Loscocco, PhD, Fabio Fuligni, Eliana Zuffa, MD, Alberto Sensi, MD, Alfonso Zaccaria, MD, Gerardo Musuraca, MD, Barbara Giannini, Alessandro Lucchesi, Francesca Fabbri, Anna Maria Mianulli, Patrizia Tosi, MD, Michela Tonelli, Anna Candoni, MD, Renato Fanin, Giovanni Sparaventi, Marco Gobbi, MD, Marino Clavio, Marco Rocchi, Pier Paolo Piccaluga, MD PhD, Alessandro Isidori, MD PhD
Journal: Blood
Blood (2015) 126 (23): 329.
https://doi.org/10.1182/blood.V126.23.329.329
Published: 2015
Journal Articles

IGH-FR1 and Leader Analysis By Next Generation Sequencing for the Detection of Clonality and Somatic Hypermutation in Lymphoid Malignancies

Pier Paolo Piccaluga, MD PhD, Anna Gazzola, PhD, Ying Huang, Jeff Panganiban, Kasey Hutt, Michael Klass
Journal: Blood
Blood (2015) 126 (23): 3868.
https://doi.org/10.1182/blood.V126.23.3868.3868
Published: 2015
Journal Articles

Prognostic Impact of TS, MTHFR and XRCC1 Genetic Variants in 113 Patients with Myelodysplastic Syndromes

Federica Loscocco, PhD, Giuseppe Visani, MD, Elisa Giacomini, Annamaria Ruzzo, Sara Galimberti, MD, Maria Teresa Voso, MD PhD, Carlo Finelli, MD, Elena Ciabatti, Emiliano Fabiani, Francesco Graziano, Sara Barulli, Antonio Volpe, MD, Domenico Magro, Pier Paolo Piccaluga, MD PhD, Fabio Fuligni, Marco Vignetti, Paola Fazi, Alfonso Piciocchi, Cristina Clissa, MD, Elisa Gabucci, Marco Rocchi, Mauro Magnani, Alessandro Isidori, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1675.
https://doi.org/10.1182/blood.V126.23.1675.1675
Published: 2015
Journal Articles

Somatic Hypermutation and V-J Gene Usage for CLL Prognosis: Evaluating Data from Miseq NGS Vs PCR-Sanger Sequencing Approaches

Ying Huang, PhD, Kasey Hutt, PhD, Jeff Panganiban, BS, Jeffrey Edward Miller, PhD, Jordan Thornes, BS, Anna Gazzola, PhD, Pier Paolo Piccaluga, MD PhD, Michael Klass, PhD
Journal: Blood
Blood (2014) 124 (21): 3317.
https://doi.org/10.1182/blood.V124.21.3317.3317
Published: 2014
Journal Articles

Panobinostat As Salvage Treatment for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible to High Dose Therapy: A Phase II Study of the Fondazione Italiana Linfomi (FIL)

Francesco Zaja, Stefano Volpetti, Annalisa Chiappella, MD, Flavia Salvi, MD, Angelo M. Carella, Adalberto Ibatici, Pier Paolo Piccaluga, Stefano A. Pileri, Davide Rossi, MD PhD, Pier Luigi Zinzani, Caterina Patti, Umberto Vitolo, Alfonso D'Arco, Alessandra Tucci, Silvia Franceschetti, Andrea Evangelista, Valentina Lenti, Renato Fanin, Alessandro Levis
Journal: Blood
Blood (2014) 124 (21): 1755.
https://doi.org/10.1182/blood.V124.21.1755.1755
Published: 2014
Journal Articles

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

Javeed Iqbal, George Wright, Chao Wang, Andreas Rosenwald, Randy D. Gascoyne, Dennis D. Weisenburger, Timothy C. Greiner, Lynette Smith, Shuangping Guo, Ryan A. Wilcox, Bin Tean Teh, Soon Thye Lim, Soon Yong Tan, Lisa M. Rimsza, Elaine S. Jaffe, Elias Campo, Antonio Martinez, Jan Delabie, Rita M. Braziel, James R. Cook, Raymond R. Tubbs, German Ott, Eva Geissinger, Philippe Gaulard, Pier Paolo Piccaluga, Stefano A. Pileri, Wing Y. Au, Shigeo Nakamura, Masao Seto, Francoise Berger, Laurence de Leval, Joseph M. Connors, James Armitage, Julie Vose, Wing C. Chan, Louis M. Staudt
Journal: Blood
Blood (2014) 123 (19): 2915–2923.
https://doi.org/10.1182/blood-2013-11-536359
Published: 2014
Includes: Supplemental data
Journal Articles

Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma

Giovanni Franco, Carla Guarnotta, Barbara Frossi, Pier Paolo Piccaluga, Emanuela Boveri, Alessandro Gulino, Fabio Fuligni, Alice Rigoni, Rossana Porcasi, Salvatore Buffa, Elena Betto, Ada Maria Florena, Vito Franco, Emilio Iannitto, Luca Arcaini, Stefano Aldo Pileri, Carlo Pucillo, Mario Paolo Colombo, Sabina Sangaletti, Claudio Tripodo
Journal: Blood
Blood (2014) 123 (12): 1836–1849.
https://doi.org/10.1182/blood-2013-04-497271
Published: 2014
Includes: Supplemental data
Journal Articles

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Brief Report
Oreofe Odejide, Oliver Weigert, Andrew A. Lane, Dan Toscano, Matthew A. Lunning, Nadja Kopp, Sunhee Kim, Diederik van Bodegom, Sudha Bolla, Jonathan H. Schatz, Julie Teruya-Feldstein, Ephraim Hochberg, Abner Louissaint, David Dorfman, Kristen Stevenson, Scott J. Rodig, Pier Paolo Piccaluga, Eric Jacobsen, Stefano A. Pileri, Nancy L. Harris, Simone Ferrero, Giorgio Inghirami, Steven M. Horwitz, David M. Weinstock
Journal: Blood
Blood (2014) 123 (9): 1293–1296.
https://doi.org/10.1182/blood-2013-10-531509
Published: 2014
Includes: Supplemental data
Journal Articles

Inhibition Of Histone Deacetylases With Panobinostat As a Treatment For Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: A Phase II Study By The Fondazione Italiana Linfomi

Francesco Zaja, Flavia Salvi, MD, Silvia Franceschetti, Gianluca Gaidano, Marco Ladetto, Manuela Zanni, Gian Matteo Pica, Angelo Michele Carella, Annalisa Chiappella, Stefano Volpetti, Pier Luigi Zinzani, Alfonso Maria D'Arco, Andrea Evangelista, Alessandra Tucci, Pier Paolo Piccaluga, MD, PhD, Stefano A. Pileri, Renato Fanin, MD, Alessandro Levis
Journal: Blood
Blood (2013) 122 (21): 3047.
https://doi.org/10.1182/blood.V122.21.3047.3047
Published: 2013
Journal Articles

Molecular Profiling Of Blastic Plasmacytoid Dendritic CELL Neoplasm Reveals A Unique Pattern and Suggests Selective Sensitivity To NF-KB Pathway Inhibition

Pier Paolo Piccaluga, MD, PhD, Maria Rosaria Sapienza, PhD, Fuligni Fabio, MS, Agostinelli Claudio, MD. PhD, Tripodo Claudio, MD, Righi Simona, BS, Maria Antonella Laginestra, PhD, Pileri Alessandro, MD, PhD, Rossi Maura, PhD, Francesca Ricci, BS, Anna Gazzola, PhD, Claudia Mannu, BS, Francesca Ulbar, BS, Mario Arpinati, MD, PhD, Marco Paulli, Davide Gibellini, MD, Livio Pagano, MD, Nicola Pimpinelli, MD, Lorenzo Cerroni, MD, Carlo M. Croce, MD, Fabio Facchetti, MD, Stefano A Pileri, MD
Journal: Blood
Blood (2013) 122 (21): 2502.
https://doi.org/10.1182/blood.V122.21.2502.2502
Published: 2013
Journal Articles

The Mutational Status Of Genes Involved In DNA Repair and Folate Pathway Predicts Overall Survival Of Patients With Low-Risk, Untreated Myelodysplastic Syndrome

Alessandro Isidori, MD, PhD, Annamaria Ruzzo, PhD, Federica Loscocco, Maria Teresa Voso, M.D., Francesco Graziano, Sara Barulli, Emanuele Canestrari, Antonio Volpe, MD, Domenico Magro, MD, Pier Paolo Piccaluga, MD, PhD, Fabio Fuligni, Stefania Paolini, Teresa Ricciardi, Paola Picardi, Elisa Giacomini, Marco Rocchi, Mauro Magnani, Giuseppe Visani, MD
Journal: Blood
Blood (2013) 122 (21): 2815.
https://doi.org/10.1182/blood.V122.21.2815.2815
Published: 2013
Journal Articles

Low-Dose Lenalidomide Plus Low Dose Cytarabine Induce Complete Remission That Can Be Predicted By Genetic Profiling In Very Elderly Acute Myeloid Leukemia Patients

Giuseppe Visani, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Federica Loscocco, Pier Paolo Piccaluga, Fabio Fuligni, Anna Gazzola, PhD, Maura Rossi, Antonella Laginestra, Maria Rita Caraci, Cira Riccardi, Axel Visani, Sara Barulli, Barbara Guiducci, Teresa Ricciardi, Giovanni Sparaventi, Marco Rocchi, Alessandro Isidori, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 496.
https://doi.org/10.1182/blood.V122.21.496.496
Published: 2013
Journal Articles

The Combination Of Hypomethylating Agents and Histone Deacetylase Inhibitors(HDACi) Are Synergistically Cytotoxic and Reverse The Malignant Phenotype In Preclinical Models Of T-Cell Lymphoma

Owen A. O'Connor, MD, PhD, Enrica Marchi, MD, PhD, Kelly Zullo, BS, Luigi Scotto, PhD, Jennifer E. Amengual, MD, Fabio Fuligni, Pier Luigi Zinzani, MD, Stefano A. Pileri, Pier Paolo Piccaluga, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 646.
https://doi.org/10.1182/blood.V122.21.646.646
Published: 2013
Journal Articles

Loss-Of-Function Mutations In The Splicing Factor ZRSR2 Are Common In Blastic Plasmacytoid Dendritic Cell Neoplasm and Have Male Predominance

Justin Taylor, MD, Sunhee S. Kim, Kristen E. Stevenson, MS, Akinori Yoda, PhD, Nadja Kopp, Abner Louissaint, MD, PhD, Nancy Lee Harris, MD, Ephraim P. Hochberg, MD, Yi-Bin Chen, MD, Scott B. Lovitch, MD, PhD, Daniel J DeAngelo, MD, PhD, Martha Wadleigh, MD, David P. Steensma, MD, Gabriela Motyckova, MD, PhD, Richard M. Stone, MD, Donna S. Neuberg, ScD, Fabrice Jardin, MD, PhD, Pier Paolo Piccaluga, MD, PhD, David M. Weinstock, MD, Andrew A. Lane, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 741.
https://doi.org/10.1182/blood.V122.21.741.741
Published: 2013
Journal Articles

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

Michela Boi, Andrea Rinaldi, Ivo Kwee, Paola Bonetti, Maria Todaro, Fabrizio Tabbò, Roberto Piva, Paola M. V. Rancoita, András Matolcsy, Botond Timar, Thomas Tousseyn, Socorro Maria Rodríguez-Pinilla, Miguel A. Piris, Sílvia Beà, Elias Campo, Govind Bhagat, Steven H. Swerdlow, Andreas Rosenwald, Maurilio Ponzoni, Ken H. Young, Pier Paolo Piccaluga, Reinhard Dummer, Stefano Pileri, Emanuele Zucca, Giorgio Inghirami, Francesco Bertoni
Journal: Blood
Blood (2013) 122 (15): 2683–2693.
https://doi.org/10.1182/blood-2013-04-497933
Published: 2013
Includes: Supplemental data
Journal Articles

Gene Expression Signatures That Delineate Biologic and Prognostic Subgroups in Peripheral T-Cell Lymphoma

Javeed Iqbal, M.Sc, PhD, George W. Wright, PhD, Andreas Rosenwald, MD, Randy D. Gascoyne, MD, Dennis D Weisenburger, MD, Chao Wang, MD, Timothy C. Greiner, MS, MD, Bin Tean Teh, MD, PhD, Philippe Gaulard, Pier Paolo Piccaluga, Sr., MD, PhD, Stefano A. Pileri, MD, Lynette Smith, MS, Lisa M. Rimsza, MD, Elaine S. Jaffe, MD, Elias Campo, MD, PhD, Jan Delabie, MD, PhD, Rita M. Braziel, MD, James R. Cook, MD, PhD, Raymond R. Tubbs, DO, Wing Y Au, Shigeo Nakamura, M.D., Ph.D., Masao Seto, MD, PhD, Francoise Berger, MD, Laurence de Leval, MD PhD, James O. Armitage, MD, Julie M Vose, MD, MBA, Louis M. Staudt, MD, PhD, Wing Chung Chan, MD
Journal: Blood
Blood (2012) 120 (21): 679.
https://doi.org/10.1182/blood.V120.21.679.679
Published: 2012
Journal Articles

Minimal Residual Disease Evaluated As Bcl2/Igh Rearrangement After Conventional Treatment Does Significantly Impact On Progression-Free Survival of Patients Affected by Follicular Lymphoma: The Experience of the Ancillary Trial Conducted by the Fondazione Italiana Linfomi (FIL)

Sara Galimberti, Stefano Luminari, Elena Ciabatti, Rossana Testi, Alessandra Dondi, Marco Ladetto, MD, Pier Paolo Piccaluga, Sr., MD, PhD, Ilaria Del Giudice, Anna Gazzola, Luigia Monitillo, PhD, Barbara Mantoan, Ph.D, Irene della Starza, Marzia Cavalli, Luca Arcaini, Alessandra Tucci, Francesco Di Raimondo, Luigi Rigacci, MD, Alessandro Pulsoni, Umberto Vitolo, Daniele Vallisa, MD, Giovanni Bertoldero, MD, Gianluca Gaidano, MD, PhD, Mario Petrini, M.D., Ph.D., Massimo Federico, MD
Journal: Blood
Blood (2012) 120 (21): 3653.
https://doi.org/10.1182/blood.V120.21.3653.3653
Published: 2012